ProFound Therapeutics

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Oak Hill Licenses Roche’s Rugonersen,

“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office

Flagship Pioneering , the self-described venture creation company, initiated ProFound Therapeutics four years ago with $75m funding and an undisclosed cash runaway. "The scientific opportunity here

Pfizer is progressing its 10-program partnership with Flagship Pioneering , opting to explore new targets in cardiovascular and renal disease with Flagship-founded somatic genomics company Quotient.